|

L19IL2 Clinical Trials

2 actively recruiting trials across 1 location

Also known as: bifikafusp alfa

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Philogen S.p.A.2

Indications

  • Cancer2
  • Melanoma Stage III1
  • Melanoma Stage IV1
  • FAP1

Other1 trial

A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
Phase 1

New York, New York1 trial

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.